Approval · Notice of Compliance 12209 · 2011
ANTISEDAN: Notice of Compliance 12209
Issued March 23, 2011
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 12209
- Date
- March 23, 2011
- Company
- Orion CorporationEspoo, --, Finland
- Product type
- Veterinary
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Therapeutic class
- Alpha2 adrenergic antagonist
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ANTISEDAN | 02237744 | Marketed |
Medicinal ingredients
- ATIPAMEZOLE HYDROCHLORIDE 5 MG per ML